Compass Therapeutics's market cap is currently $436.16M. The company's EPS TTM is $-0.355; its P/E ratio is ―; Compass Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Mar 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.89M	$ -1.90M	$ -1.62M	$ -2.40M	$ -2.12M
Operating Income	$ -50.36M	$ -41.66M	$ -81.88M	$ -27.81M	$ -34.05M
EBITDA	$ -48.47M	$ -37.39M	$ -29.61M	$ -25.32M	$ -31.19M
Net Income	$ -42.49M	$ -36.80M	$ -82.55M	$ -29.50M	$ -34.74M
Balance Sheet
Cash & Short-Term Investments	$ 152.46M	$ 186.61M	$ 144.51M	$ 47.08M	$ 25.30M
Total Assets	$ 156.88M	$ 199.65M	$ 153.76M	$ 51.91M	$ 30.38M
Total Debt	$ 1.73M	$ 2.94M	$ 4.04M	$ 9.33M	$ 14.87M
Net Debt	$ -22.50M	$ -32.01M	$ -140.48M	$ -37.74M	$ -10.43M
Total Liabilities	$ 8.34M	$ 18.01M	$ 13.68M	$ 11.97M	$ 148.98M
Stockholders' Equity	$ 148.54M	$ 181.64M	$ 140.08M	$ 39.95M	$ -118.60M
Cash Flow
Free Cash Flow	$ -40.65M	$ -34.34M	$ -21.23M	$ -26.91M	$ -32.21M
Operating Cash Flow	$ -40.62M	$ -34.13M	$ -19.67M	$ -26.80M	$ -31.74M
Investing Cash Flow	$ 26.96M	$ -151.20M	$ -1.77M	$ 38.00K	$ -466.00K
Financing Cash Flow	$ 2.94M	$ 75.76M	$ 118.61M	$ 48.54M	$ 37.63K

Currency in USD

Compass Therapeutics Earnings and Revenue History

Income Statement >

Compass Therapeutics Debt to Assets

Balance Sheet >

Compass Therapeutics Cash Flow

Cash Flow >

Compass Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing